ArticleNature communications2025

Targeting ceramide transfer protein sensitizes AML to FLT3 inhibitors via a GRP78-ATF6-CHOP axis.

Xiaofan Sun et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.